BML

Biomed-Lublin Wytwornia Surowic i Szczepionek SA

Biomed-Lublin Wytwornia Surowic i Szczepionek SA is a renowned pharmaceutical company located in Lublin, Poland. Since its establishment in 1950, the company has been specializing in the production of vaccines, sera, and other biological products for both human and veterinary use. Biomed-Lublin is committed to delivering high-quality and safe products that cater to the needs of patients and healthcare professionals. The company's manufacturing facilities are equipped with cutting-edge technology and adhere to strict quality control standards. Biomed-Lublin's team of experienced scientists and researchers work tirelessly to develop innovative products that address unmet medical needs and improve patient outcomes. Biomed-Lublin's product portfolio includes vaccines for infectious diseases such as hepatitis B, influenza, and tick-borne encephalitis, as well as sera for the treatment of snake bites and other venomous animal bites. The company also produces diagnostic reagents and laboratory equipment for medical professionals. With a strong commitment to research and development, Biomed-Lublin is dedicated to advancing the field of biotechnology and improving public health. The company's mission is to provide safe and effective biological products that contribute to the prevention and treatment of diseases worldwide.

Instrument specification in OANDA

Name
Valūta
Simbols
Minimālā pasūtījuma vērtība
Ticker
Tirdzniecības laiks
Type
Pasūtījumu pieņemšanas laiks
ISIN

Sāciet tirgot tagad ar ātru konta atvēršanu.

Reģistrējieties tagad, lai tirgotos aktīvākajos tirgos

ATVER KONTU
OANDA ir vairāk nekā 20 gadus tirgū strādājošs brokeris, kas lepojas ar vadošajiem analīzes rīkiem un tūkstošiem apmierinātu klientu, un ir godalgots starpnieks.
Iegūstiet piekļuvi visaktīvākajiem pasaules tirgiem ar tūkstošiem tirdzniecības instrumentu, kā arī vadošajiem tehniskajiem rīkiem, kas palīdz veikt analīzi.
Tirdzniecība bez liekām izmaksām un pilnīga cenu pārredzamība - OANDA piedāvā nulles komisijas maksu par galvenajiem instrumentiem un pārredzamu cenu noteikšanu.
Scroll to top